From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment

Published:2023-09-19 Issue: Volume: Page:
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Zhang Zeyu,Tao Jinxin,Qiu Jiangdong,Cao Zhe,Huang Hua,Xiao Jianchun,Zhang Taiping

Funder

National High Level Hospital Clinical Research Funding

National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-023-00872-z.pdf

Reference138 articles.

1. P. Garin-Chesa, L.J. Old, W.J. Rettig, Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. U S A 87, 7235–7239 (1990)

2. E. Puré, R. Blomberg, Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene 37, 4343–4357 (2018)

3. Y. Huang, A.E. Simms, A. Mazur, S. Wang, N.R. León, B. Jones, N. Aziz, T. Kelly, Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Clin. Exp. Metas. 28, 567–579 (2011)

4. N. Higashino, Y.-I. Koma, M. Hosono, N. Takase, M. Okamoto, H. Kodaira, M. Nishio, M. Shigeoka, Y. Kakeji, H. Yokozaki, Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Lab. Invest. 99, 777–792 (2019)

5. F. Liu, L. Qi, B. Liu, J. Liu, H. Zhang, D. Che, J. Cao, J. Shen, J. Geng, Y. Bi, L. Ye, B. Pan, Y. Yu, Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One 10, e0116683 (2015)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives;European Journal of Medicinal Chemistry;2024-11

2. Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors;Cancer Science;2024-08-21

3. Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-10

4. Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine;Seminars in Nuclear Medicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3